The Claim
Oral supplementation with lutein and zeaxanthin reduces the rate of geographic atrophy progression toward the central macula by approximately 35% in individuals with non-central geographic atrophy due to age-related macular degeneration when β-carotene is not concurrently consumed.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking lutein and zeaxanthin supplements by mouth slows the expansion of geographic atrophy in the macula by about 35% in people with age-related macular degeneration who do not take β-carotene.
See the scientific wording
Oral supplementation with lutein and zeaxanthin slows the rate of geographic atrophy progression toward the central macula by approximately 35% in individuals with non-central geographic atrophy due to age-related macular degeneration, particularly when β-carotene is not concurrently consumed, as demonstrated in the AREDS2 trial over a mean follow-up of 3.3 years.
When people take lutein and zeaxanthin supplements, these compounds build up in the center of the eye, where they block harmful molecules made by light and oxygen. This protection keeps the cells that support vision from dying, which stops the blind spot from spreading toward the very center of vision.
What the research says
1 studyTaking lutein and zeaxanthin supplements slowed the spread of blind spots toward the center of the eye by about 35% in people with advanced eye disease, but only when they didn’t also take beta-carotene.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.